
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 0.156564526951 | 44.71 | 49.795 | 43.4 | 726116 | 45.85956887 | CS |
4 | -6.23 | -12.2132915115 | 51.01 | 52.46 | 43.06 | 482159 | 47.03500075 | CS |
12 | -1.93 | -4.13187754228 | 46.71 | 52.46 | 41.5 | 507322 | 46.77256117 | CS |
26 | -4.18 | -8.53758169935 | 48.96 | 60.92 | 41.5 | 589308 | 50.45536568 | CS |
52 | 1.78 | 4.13953488372 | 43 | 60.92 | 36.61 | 522090 | 47.86835015 | CS |
156 | 44.4604 | 13911.2640801 | 0.3196 | 60.92 | 0.1302 | 729600 | 16.92379237 | CS |
260 | 41.84 | 1423.1292517 | 2.94 | 60.92 | 0.1302 | 811084 | 9.7786465 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales